In developing McKesson's medication adherence solutions, how do we weigh patient privacy concerns against the potential for improved health outcomes through more comprehensive data collection?

Introduction

In developing McKesson's medication adherence solutions, we're facing a critical trade-off between patient privacy concerns and the potential for improved health outcomes through more comprehensive data collection. This scenario touches on the core of healthcare technology ethics and efficacy. I'll analyze this trade-off by examining the product context, stakeholder impacts, potential experiments, and decision frameworks to guide our approach.

Step 1

Clarifying Questions (3 minutes)

• Based on recent healthcare regulations, I'm thinking HIPAA compliance is a major factor here. Could you confirm if there are any specific regulatory changes or concerns driving this discussion?

Why it matters: Helps frame the legal constraints and potential risks Expected answer: Recent updates to data protection laws are increasing scrutiny Impact on approach: Would prioritize privacy-preserving technologies in our solution

• Considering our business model, I assume improved health outcomes could lead to expanded partnerships with healthcare providers. How does this initiative align with our current revenue streams and growth strategy?

Why it matters: Aligns solution with business objectives and potential ROI Expected answer: It's a key pillar in our value-based care offerings Impact on approach: Would justify higher investment in data analytics capabilities

• Looking at user segments, I'm thinking about the diversity of our patient base. Can you provide insights into the demographics and tech-savviness of our target users?

Why it matters: Informs UX design and communication strategies Expected answer: Wide range, skewing older and less tech-savvy Impact on approach: Would emphasize simplicity and clear consent processes

• Regarding our technical capabilities, I'm curious about our current data infrastructure. How scalable is our system for handling potentially larger volumes of more granular patient data?

Why it matters: Determines feasibility and implementation timeline Expected answer: Current system would need significant upgrades Impact on approach: Would factor in technical debt and phased rollout

• Considering project timelines, is there a specific market opportunity or competitive pressure driving the urgency of this initiative?

Why it matters: Helps prioritize features and set realistic deadlines Expected answer: Increasing competition in the digital health space Impact on approach: Would focus on unique differentiators and faster time-to-market